Mumbai, July 16, 2014 – The Board of Directors of Unichem Laboratories Ltd at their meeting held on July 12, 2014 approved the First Quarter (Q1) Un-audited Results for FY 2014-15.
The Company’s standalone revenue from operations stood at Rs. 290.99 crs for the quarter ended June 30, 2014 against Rs. 265.57 crs recorded during the corresponding quarter of the previous year, reflecting a growth of 9.6%.
The Company’s EBITDA for the quarter stood at Rs. 43.68 crs.
The Company recorded a Net Profit After Tax of Rs. 30.19 Crores for the quarter ended June 30, 2014 as against Rs. 36.09 Crores in the corresponding quarter of the previous year.
The EPS-Diluted for the current quarter stood at Rs. 3.32 (corresponding quarter previous year: Rs. 3.98). BWI
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…
Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…